REVIEW : Respiratory Reviews in Asthma 2013

논문상세정보
' REVIEW : Respiratory Reviews in Asthma 2013' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • asthma
  • pharmacogenetics
  • phenotype
  • therapeutics
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
512 0

0.0%

' REVIEW : Respiratory Reviews in Asthma 2013' 의 참고문헌

  • Tiotropium in asthma poorly controlled with standard combination therapy
    Kerstjens HA N Engl J Med 367 : 1198 ~ 1207 [2012]
  • The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations
    Schatz M Chest 141 : 66 ~ 72 [2012]
  • The relationship between combination inhaled corticosteroid and long-acting beta-agonist use and severe asthma exacerbations in a diverse population
    Wells KE J Allergy Clin Immunol 129 : 1274 ~ 1279.e2 [2012]
  • The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacks
    Greenberg S J Allergy Clin Immunol 130 : 1071 ~ 1077.e10 [2012]
  • The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma
    Hawkins GA J Allergy Clin Immunol 130 : 510 ~ 515.e1 [2012]
  • Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma
    Eisner MD Chest 141 : 58 ~ 65 [2012]
  • Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
    Jia G J Allergy Clin Immunol 130 : 647 ~ 654.e10 [2012]
  • Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications
    Sumino K J Allergy Clin Immunol 130 : 69 ~ 75.e6 [2012]
  • Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
    Pavord ID Lancet 380 : 651 ~ 659 [2012]
  • Mepolizumab and exacerbations of refractory eosinophilic asthma
    Haldar P N Engl J Med 360 : 973 ~ 984 [2009]
  • Long-acting beta2-agonist step-off in patients with controlled asthma
    Brozek JL Arch Intern Med 172 : 1365 ~ 1375 [2012]
  • Genome-wide association study to identify genetic determinants of severe asthma
    Wan YI Thorax 67 : 762 ~ 768 [2012]
  • Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial
    Calhoun WJ JAMA 308 : 987 ~ 997 [2012]
  • Azithromycin for prevention of exacerbations of COPD
    Albert RK N Engl J Med 365 : 689 ~ 698 [2011]
  • Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
    Brusselle GG Thorax 68 : 322 ~ 329 [2013]
  • A trial of clarithromycin for the treatment of suboptimally controlled asthma
    Sutherland ER J Allergy Clin Immunol 126 : 747 ~ 753 [2010]